U.S. National Cancer Institute, 2026-10-31: NCI's public drug-data resource is CellMiner, a database of molecular and pharmacological data for the 60 NCI-60 cell lines – not a curated database of repurposed drugs.
CellMiner is a database and query tool designed for the cancer research community to facilitate integration and study of molecular and pharmacological data for the NCI-60 cancerous cell lines.
U.S. National Cancer Institute, 2026-10-31: NCI's public drug-data resource is CellMiner, a database of molecular and pharmacological data for the 60 NCI-60 cell lines – not a curated database of repurposed drugs. F7. Access date 2026-11-19; the page prints 'Version 2026.2 – 10/31/2026'. It describes a cell-line pharmacology resource (100,000+ compounds screened since 1990) with no repurposing-indication curation. Nothing on the NCI site located in this run describes an 'NCI database of repurposed drugs'; the named repurposed-drugs database is the Anticancer Fund's ReDO_DB (IVA-61). Study type: other.
